Pfizer Ventures has led a $102m series A for Capstan Therapeutics while Globis Capital Partners took part in an $85.4m round for Andpad.

Access Industries, Pfizer and SR One were among the investors in a $125m round for Nimbus Therapeutics while Aerwins agreed a reverse takeover.

Alphabet led a $1bn round for its Verily subsidiary while Kimco Realty and The Silverman Group were part of Gotham Greens’ $310m series E.

SHV and DELA took part in an $80m round for Lightyear while Tata Sons provided $40m in funding for Tata 1mg.

Eli Lilly took part in a $50m series A1 round for Neukio Biotherapeutics while Itochu led Docquity’s $44m series C.

SK has provided $50m in funding for Ascend Elements while ServiceNow took part in a $35.6m series C round for Fairmarkit.

Peijia Medical participated in JenaValve’s $100m series C round while L Catterton led Planted Foods’ series B extension, lifting it to $93m.

FTX and Coinbase took part in a $200m round for NFT game developer Limit Break while Schaeffler, Kingspan and Marcegaglia backed H2 Green Steel’s $190m series B.

Bertelsmann-backed paywall management software provider Zephr is set to be acquired by Zuora in a $44m deal while Meituan co-led a $875m round for EV battery producer Sunwoda.

Intel Capital co-led an extension that took Anyscale’s series C round to $199m while Saudi Aramco's Prosperity7 fund helped Zilliz lift its series B to $103m.